BIOMAT Database Logo BIOMAT Database Logo

Indomethacin-induced asthma in aspirin-sensitive patients. 1977

N M Johnson, and A E Black, and S W Clarke

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

N M Johnson, and A E Black, and S W Clarke
Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma.
April 1994, Lancet (London, England),
N M Johnson, and A E Black, and S W Clarke
Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma.
February 1994, Lancet (London, England),
N M Johnson, and A E Black, and S W Clarke
Aspirin sensitive asthma.
February 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
N M Johnson, and A E Black, and S W Clarke
Aspirin-sensitive asthma.
April 2005, Internal medicine journal,
N M Johnson, and A E Black, and S W Clarke
Aspirin-sensitive asthma.
March 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
N M Johnson, and A E Black, and S W Clarke
Aspirin-sensitive asthma.
March 1985, Chest,
N M Johnson, and A E Black, and S W Clarke
Aspirin-sensitive asthma.
December 1981, The Journal of allergy and clinical immunology,
N M Johnson, and A E Black, and S W Clarke
Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.
September 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
N M Johnson, and A E Black, and S W Clarke
Salsalate cross-sensitivity in aspirin-sensitive patients with asthma.
November 1990, The Journal of allergy and clinical immunology,
N M Johnson, and A E Black, and S W Clarke
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
February 1996, American journal of respiratory and critical care medicine,
Copied contents to your clipboard!